Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001957554-26-000007

Chief Financial Officer gave up 6,449 shares (to pay taxes)

  • Chief Financial Officer acquired 22,025 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Balthaser Kevin · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-03 Exercise or conversion : show line 1 in the form +22,025 192,204 D
2026-02-03 Shares withheld for taxes : show line 2 in the form −6,449 $3.47 $22,378 185,755 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −22,025 66,075 D
Loading xslF345X05/form4-02052026_090243.xml…